PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter and full year 2022 financial results on Thursday, February 16, 2023, at 4:30 pm Eastern Time.
| MENLO PARK, Calif., Feb. 2, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter and full year 2022 financial results on Thursday, February 16, 2023, at 4:30 pm Eastern Time.
The call will be webcast and may be accessed at PacBio’s website at: https://investor.pacificbiosciences.com/. Date: Thursday, February 16, 2023 at 4:30 pm ET (1:30 pm PT) If using the dial-in option, please dial into the call five to ten minutes prior to start time using the appropriate number above and ask to join the “PacBio Q4 Earnings Call.” About PacBio Pacific Biosciences of California, Inc. is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. Our products and technology under development stem from two highly differentiated core technologies focused on accuracy, quality and completeness which include our existing HiFi long read sequencing and our emerging SBB® short read sequencing technologies. Our products address solutions across a broad set of research applications including human germline sequencing, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information please visit www.pacb.com and follow @PacBio. Contacts Media:
SOURCE Pacific Biosciences of California, Inc. | ||
Company Codes: NASDAQ-NMS:PACB |
View original content to download multimedia:
